What is the recommended Lantus (insulin glargine) dose, carb ratio, and correction scale for a patient with type 2 diabetes and cellulitis at an ambulatory infusion site, who received hydrocortisone (cortisol) 100mg 10 hours ago, and is currently on 30 units of Lantus (insulin glargine) with a 1:10 carb ratio and 1:15 correction scale?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Management in Type 2 Diabetes with Cellulitis and Recent Glucocorticoid Administration

Immediate Insulin Dose Adjustments Required

Increase Lantus to 45 units daily (50% increase from baseline 30 units) and maintain current carb ratio and correction scale for now, with plan to reassess and likely intensify prandial coverage within 3 days based on glucose monitoring. 1

Basal Insulin (Lantus) Adjustment

  • Increase Lantus from 30 units to 45 units once daily due to the combined hyperglycemic effects of cellulitis (acute infection) and recent hydrocortisone administration 1

  • Glucocorticoids cause significant insulin resistance, with hydrocortisone 100mg IV producing measurable effects on glucose metabolism for 12-24 hours, requiring increased insulin doses 2

  • For patients on glucocorticoids, adding 0.1-0.3 units/kg/day of basal insulin to the usual regimen is recommended, with doses determined by steroid dose and oral intake 3

  • The 50% increase (from 30 to 45 units) represents a reasonable starting adjustment given the dual stressors of infection and steroid administration 1

Carbohydrate Ratio Adjustment

  • Maintain the 1:10 carb ratio initially (1 unit per 10 grams carbohydrate), but monitor closely as this will likely need tightening to 1:8 or 1:7 within 2-3 days 3

  • The current ratio may be insufficient given the acute illness and steroid effects, but making too many simultaneous changes increases hypoglycemia risk and makes it difficult to identify which adjustment was responsible for any problems 1

  • Glucocorticoids primarily cause daytime hyperglycemia with peak effects 4-6 hours after administration, disproportionately affecting postprandial glucose control 1

Correction Scale Adjustment

  • Maintain the 1:15 correction scale initially (1 unit lowers glucose by 15 mg/dL), but plan to reassess within 48-72 hours as insulin resistance from infection and steroids will likely require tightening to 1:12 or 1:10 1, 3

  • The correction factor (insulin sensitivity factor) should be recalculated using the formula 1500/TDD once the new total daily dose stabilizes 3

Critical Monitoring Requirements

  • Check fasting and pre-meal glucose daily during this acute illness period, with particular attention to pre-lunch and pre-dinner readings to assess adequacy of prandial coverage 1

  • Monitor for signs of worsening infection or inadequate glycemic control that would warrant further insulin intensification 1

  • If fasting glucose remains ≥180 mg/dL after 3 days, increase Lantus by an additional 4 units 3

  • If fasting glucose is 140-179 mg/dL after 3 days, increase Lantus by 2 units 3

Anticipated Need for Prandial Insulin Intensification

  • Be prepared to add or increase prandial insulin coverage within 3-5 days if pre-meal and postprandial glucose readings remain elevated despite basal insulin optimization 1, 3

  • When cellulitis resolves and steroid effects wane (typically 24-48 hours after last dose), insulin requirements will decrease and doses must be reduced by 20-30% to prevent hypoglycemia 1, 3

  • The current basal dose of 30 units for a patient on 1:10 carb ratio suggests total daily insulin requirements of approximately 50-60 units, which may increase to 75-90 units during acute illness 3

Special Considerations for Cellulitis

  • Cellulitis requiring hospitalization is associated with undiagnosed or poorly controlled diabetes in 21-37% of cases, indicating this patient may have had suboptimal baseline control 4

  • Acute infection increases insulin resistance through inflammatory cytokines and counter-regulatory hormones, requiring 30-50% increases in insulin doses 1

  • As the infection resolves with antibiotic therapy, insulin requirements will decrease, necessitating close monitoring and dose reduction to prevent hypoglycemia 1

Common Pitfalls to Avoid

  • Do not delay insulin intensification in the setting of acute illness and steroid administration—waiting for "things to settle down" will result in prolonged hyperglycemia and worse outcomes 1

  • Do not continue escalating basal insulin beyond 0.5 units/kg/day (approximately 60-70 units for most adults) without adding or intensifying prandial coverage, as this leads to overbasalization with increased hypoglycemia risk 3

  • Do not forget to reduce insulin doses by 20-30% once the infection resolves and steroid effects dissipate (24-48 hours after last dose), as failure to do so will cause severe hypoglycemia 1, 3

  • Do not rely solely on correction insulin (sliding scale)—scheduled basal-bolus regimens with nutritional and correction components produce better glycemic control and fewer treatment failures than correction insulin alone 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cellulitis and the occult diabetic.

The Australian and New Zealand journal of surgery, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.